In Search of the Right Sequence for Venetoclax in CLL

Researchers reveal the results of the phase 2 CLL2-BAG trial, which evaluated sequential bendamustine followed by obinutuzumab and venetoclax in patients with CLL.

from Latest articles from Cancer Therapy Advisor News https://ift.tt/2Lcp5Ub